Absci Corporation is a biotechnology business based in the US. Absci Corporation shares (ABSI) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.82 – an increase of 34.41% over the previous week. Absci Corporation employs 155 staff and has a trailing 12-month revenue of around $4.2 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $5.82 |
|---|---|
| 52-week range | $2.45 - $6.72 |
| 50-day moving average | $3.47 |
| 200-day moving average | $3.87 |
| Wall St. target price | $8.63 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.93 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.82 from 2025-02-14
| 1 week (2025-02-07) | 24.63% |
|---|---|
| 1 month (2025-01-17) | 100.69% |
| 3 months (2024-11-15) | 104.93% |
| 6 months (2024-08-16) | 45.14% |
| 1 year (2024-02-16) | 9.19% |
|---|---|
| 2 years (2023-02-16) | 123.85% |
| 3 years (2022-02-16) | 8.94 |
| 5 years (2020-02-13) | N/A |
| Revenue TTM | $4.2 million |
|---|---|
| Gross profit TTM | $-45,523,000 |
| Return on assets TTM | -27.4% |
| Return on equity TTM | -49.11% |
| Profit margin | 0% |
| Book value | $1.76 |
| Market Capitalization | $574.3 million |
TTM: trailing 12 months
We're not expecting Absci Corporation to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Absci Corporation's shares have ranged in value from as little as $2.45 up to $6.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Absci Corporation's is 2.187. This would suggest that Absci Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Absci Corporation's beta into context you can compare it against those of similar companies.
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington. .
Spot dogecoin ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.